Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1T cell responses

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 1, 2004, Pages 82-88

  Oka, Hideki ^a   Sasaki, Hidetaka ^a   Shiraishi, Yumiko ^a   Emori, Yutaka ^a   Yoshinaga, Koji ^a   Takei, Mineo ^a  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Immunomodulator; Mycobacterium tuberculosis; Radiotherapy; T cell response; Z 100

Indexed keywords

ARABINOMANNAN; CD4 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; Z 100; CYTOKINE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; IMMUNOLOGICAL ADJUVANT; LIPID; MANNAN; RADIOSENSITIZING AGENT; SPECIFIC SUBSTANCE MARUYAMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG ISOLATION; IMMUNOMODULATION; KNOCKOUT MOUSE; MALE; MELANOMA B16; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SURVIVAL; T LYMPHOCYTE; X IRRADIATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CD4+ T LYMPHOCYTE; EXPERIMENTAL MELANOMA; IMMUNOLOGY; METABOLISM; MULTIMODALITY CANCER THERAPY; RADIATION EXPOSURE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD11C; CD4-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; CYTOKINES; INDICATORS AND REAGENTS; INTERLEUKIN-12; LIPIDS; MALE; MANNANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS; TH1 CELLS;

EID: 3442901128     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.82     Document Type: Article

References (52)

1. Kobatake H., Suekane T., Murakami Y., Niwa S., Okahira A., Kushida H., Yakugaku Zasshi, 101, 713-722 (1981).
2. Suzuki I., Okuda M., Matumura A., Kushida H., Pharmacometrics, 14, 363-367 (1977).
3. Kawamura I., Mitsuyama M., Nomoto K., Immunopharmacol. Immunotoxicol., 12, 331-343 (1990).
4. Kobayashi M., Herndon D. N., Pollard R. B., Suzuki F., Immunol. Lett., 40, 199-205 (1994).
5. Sasaki H., Kobayashi M., Pollard R. B., Suzuki F., Pathobiology, 69, 96-103 (2001).
6. Wada J., Sasaki H., Hayashi Y., Kushida H., Takahashi M., Nomoto K., Proceedings of Japan Cancer Association., 46th Annual Meeting, Tokyo, 1987, p. 386.
7. Sasaki H., Schmitt D., Hayashi Y., Pollard R. B., Suzuki F., Cancer Res., 50, 4032-4037 (1990).
8. Hayashi Y., Ebina T., Suzuki F., Ishida N., Microbiol. Immunol., 25, 305-316 (1981).
9. Kobayashi M., Nakajima N., Pollard R. B., Suzuki F., Proc. AACR, 36, 467 (1995).
10. Hayashi Y., Yamaguchi I., Kobayashi M., Shimizu T., Matsuda K., Yoshida M., Kumakura M., Hirashima K., J. Radiat. Res. (Tokyo), 31, 375-388 (1990).
11. Kobayashi M., Pollard R. B., Suzuki F., Anticancer Drugs, 8, 156-163 (1997).
12. Oka H., Shiraishi Y., Sasaki H., Yoshinaga K., Emori Y., Takei M., Biol. Pharm. Bull., 26, 1336-1341 (2003).
13. Oka H., Emori Y., Sasaki H., Shiraishi Y., Yoshinaga K., Kurimoto T., Microbiol. Immunol., 46, 343-351 (2002).
14. Oka H., Emori Y., Ohya O., Kobayashi N., Sasaki H., Tanaka Y., Hayashi Y., Nomoto K., Immunol. Lett., 70, 109-117 (1999).
15. Mukai M., Kubota S., Morita S., Akanuma A., Cancer, 75, 2276-2280 (1995).
16. Inomata T., Goodman G. B., Fryer C. J., Chaplin D. J., Palcic B., Lam G. K., Nishioka A., Ogawa Y., Br. J. Cancer Suppl., 27, S122-125 (1996).
17. Okamura K., Suzuki M., Chihara T., Fujiwara A., Fukuda T., Goto S., Ichinohe K., Jimi S., Kasamatsu T., Kawai N., Mizuguchi K., Mori T., Nakano H., Noda K., Sekiba K., Suzuki K., Suzuki T., Takahashi K., Takeuchi K., Takeuchi S., Yajima A., Ogawa N., Biotherapy, 1, 103-107 (1989).
18. Tsuneoka K., Ishihara H., Dimchev A. B., Nomoto K., Yokokura T., Shikita M., J. Radiat. Res. (Tokyo), 35, 147-156 (1994).
19. Motoki K., Maeda K., Ueno H., Kobayashi E., Uchida T., Fukushima H., Koezuka Y., Oncol. Res., 8, 155-162 (1996).
20. Fiorentino D. F., Bond M. W., Mosmann T. R., J. Exp. Med., 170, 2081-2095 (1989).
21. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., J. Immunol., 136, 2348-2357 (1986).
22. Macatonia S. E., Hosken N. A., Litton M., Vieira P., Hsieh C. S., Culpepper J. A., Wysocka M., Trinchieri G., Murphy K. M., O'Garra A., J. Immunol., 154, 5071-5079 (1995).
23. Macatonia S. E., Hsieh C. S., Murphy K. M., O'Garra A., Int. Immunol., 5, 1119-1128 (1993).
24. Romagnani S., Annu. Rev. Immunol., 12, 227-257 (1994).
25. Gajewski T. F., Schell S. R., Nau G., Fitch F. W., Immunol. Rev., 111, 79-110 (1989).
26. Swain S. L., Weinberg A. D., English M., Huston G., J. Immunol., 145, 3796-3806 (1990).
27. Kobayashi M., Kobayashi H., Pollard R. B., Suzuki F., J. Immunol., 160, 5869-5873 (1998).
28. Okamoto T., Harada M., Tamada K., Yoshida H., Ito O., Kong Y. Y., Takenoyama M., Hirashima C., Matsuzaki G., Nomoto K., Int. J. Cancer., 70, 598-605 (1997).
29. Takeuchi T., Ueki T., Sasaki Y., Kajiwara T., Li B., Moriyama N., Kawabe K., Cancer Immunol. Immunother., 43, 375-381 (1997).
30. Okamoto M., Ohe G., Oshikawa T., Furuichi S., Nishikawa H., Tano T., Ahmed S. U., Yoshida H., Moriya Y., Saito M., Sato M., Cancer Immunol. Immunother., 50, 408-416 (2001).
31. Murata Y., Shimamura T., Tagami T., Takatsuki F., Hamuro J., Int. Immunopharmacol., 2, 673-689 (2002).
32. Inoue A., Kodama N., Nanba H., Biol. Pharm. Bull., 25, 536-540 (2002).
33. Stern B. V., Boehm B. O., Tary-Lehmann M., J. Immunol., 168, 6099-6105 (2002).
34. Kobayashi M., Fujita K., Katakura T., Utsunomiya T., Pollard R. B., Suzuki F., Anticancer Res., 22, 4053-4058 (2002).
35. Hayakawa Y., Fujii H., Hase K., Ohnishi Y., Sakukawa R., Kadota S., Namba T., Saiki I., Biol. Pharm. Bull., 21, 1154-1159 (1998).
36. Yoshino S., Tabata T., Hazama S., Iizuka N., Yamamoto K., Hirayama M., Tangoku A., Oka, M., Anticancer Res., 20, 4707-4711 (2000).
37. Iinuma H., Okinaga K., Tamura J., Kumagai H., Sekine T., Inaba T., Fukushima R., Biotherapy (Japan), 14, 29-32 (2000).
38. Luo Y., Chen X., Downs T. M., DeWolf W. C., O'Donnell M. A., J. Immunol., 162, 2399-2405 (1999).
39. Hrouda D., Baban B., Dunsmuir W. D., Kirby R. S., Dalgleish A. G., Br. J. Urol., 82, 568-573 (1998).
40. Brunda M. J., Luistro L., Warrier R. R., Wright R. B., Hubbard B. R., Murphy M., Wolf S. F., Gately M. K., J. Exp. Med., 178, 1223-1230 (1993).
41. Kodama T., Takeda K., Shimozato O., Hayakawa Y., Atsuta M., Kobayashi K., Ito M., Yagita H., Okumura K., Eur. J. Immunol., 29, 1390-1396 (1999).
42. Shinomiya Y., Harada M., Kurosawa S., Okamoto T., Terao H., Matsuzaki G., Shirakusa T., Nomoto K., Immunobiology, 193, 439-455 (1995).
43. Vicari A. P., Zlotnik A., Immunol. Today, 17, 71-76 (1996).
44. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., J. Immunol., 155, 1151-1164 (1995).
45. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G., J. Exp. Med., 170, 827-845 (1989).
46. Nastala C. L., Edington H. D., McKinney T. G., Tahara H., Nalesnik M. A., Brunda M. J., Gately M. K., Wolf S. F., Schreiber R. D., Storkus W. J., Lotze M. T., J. Immunol., 153, 1697-1706 (1994).
47. Hsieh C. S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M., Science, 260, 547-549 (1993).
48. Kang K., Kubin M., Cooper K. D., Lessin S. R., Trinchieri G., Rook A. H., J. Immunol., 156, 1402-1407 (1996).
49. Manetti R., Parronchi P., Giudizi M. G., Piccinni M. P., Maggi E., Trinchieri G., Romagnani S., J. Exp. Med., 177, 1199-1204 (1993).
50. Nikitina E. Y., Gabrilovich D. I., Int. J. Cancer, 94, 825-833 (2001).
51. Kokhaei P., Rezvany M. R., Virving L., Choudhury A., Rabbani H., Osterborg A., Mellstedt H., Leukemia, 17, 894-899 (2003).
52. Makidono R., Nippon Igaku Hoshasen Gakkai Zasshi, 56, 575-578 (1996).